Your browser is no longer supported. Please, upgrade your browser.
Settings
ADPT Adaptive Biotechnologies Corporation daily Stock Chart
ADPT [NASD]
Adaptive Biotechnologies Corporation
Index- P/E- EPS (ttm)-0.79 Insider Own1.40% Shs Outstand127.38M Perf Week4.19%
Market Cap6.35B Forward P/E- EPS next Y-1.09 Insider Trans-67.02% Shs Float82.04M Perf Month17.75%
Income-99.50M PEG- EPS next Q-0.28 Inst Own74.60% Short Float3.71% Perf Quarter4.32%
Sales92.20M P/S68.85 EPS this Y-42.00% Inst Trans4.22% Short Ratio2.84 Perf Half Y90.27%
Book/sh4.16 P/B11.61 EPS next Y-3.80% ROA-11.20% Target Price51.80 Perf Year50.02%
Cash/sh4.34 P/C11.13 EPS next 5Y3.90% ROE-17.80% 52W Range15.19 - 49.00 Perf YTD61.40%
Dividend- P/FCF- EPS past 5Y- ROI-12.90% 52W High-1.45% Beta-
Dividend %- Quick Ratio6.30 Sales past 5Y- Gross Margin76.30% 52W Low217.91% ATR2.35
Employees453 Current Ratio6.40 Sales Q/Q-5.00% Oper. Margin- RSI (14)65.49 Volatility5.24% 5.89%
OptionableYes Debt/Eq0.00 EPS Q/Q-90.50% Profit Margin- Rel Volume0.90 Prev Close45.82
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout- Avg Volume1.07M Price48.29
Recom1.70 SMA2013.90% SMA5018.74% SMA20038.43% Volume967,799 Change5.39%
Sep-09-20Initiated Morgan Stanley Equal-Weight $42
Jun-03-20Initiated Goldman Buy $60
Jul-23-19Initiated BTIG Research Buy $46
Jul-22-19Initiated William Blair Outperform
Jul-22-19Initiated Guggenheim Buy $47
Jul-22-19Initiated Goldman Neutral $32
Jul-22-19Initiated Cowen Outperform
Jul-22-19Initiated BofA/Merrill Buy $45
Sep-01-20 04:03PM  
Aug-11-20 01:01AM  
Aug-10-20 06:35PM  
04:05PM  
12:44PM  
08:05AM  
Aug-06-20 09:24AM  
Aug-04-20 09:30AM  
Jul-30-20 06:19AM  
Jul-28-20 06:04PM  
Jul-16-20 12:00PM  
Jul-15-20 07:47PM  
Jul-14-20 04:44PM  
Jul-09-20 04:29PM  
08:05AM  
Jun-23-20 11:54AM  
Jun-17-20 08:56AM  
Jun-15-20 10:27AM  
Jun-11-20 09:00AM  
Jun-08-20 04:03PM  
Jun-07-20 06:25AM  
May-27-20 04:03PM  
May-19-20 08:03AM  
May-18-20 02:47PM  
May-14-20 11:51AM  
May-13-20 12:31PM  
07:02AM  
May-12-20 04:03PM  
08:06AM  
May-11-20 10:57AM  
09:57AM  
May-08-20 09:09AM  
May-06-20 03:06PM  
02:50PM  
12:10PM  
08:19AM  
08:00AM  
May-05-20 12:00PM  
Apr-30-20 08:51AM  
06:39AM  
Apr-27-20 04:03PM  
Apr-20-20 08:15AM  
Apr-17-20 09:13PM  
12:40PM  
Apr-15-20 04:47PM  
08:26AM  
Apr-09-20 07:45PM  
Apr-07-20 08:35PM  
Apr-05-20 10:14AM  
Apr-03-20 10:51AM  
Apr-02-20 07:58PM  
05:50PM  
04:23PM  
04:04PM  
12:29PM  
09:34AM  
09:00AM  
Mar-27-20 02:52PM  
Mar-24-20 04:45PM  
Mar-23-20 11:06AM  
Mar-20-20 02:00PM  
01:02PM  
Feb-29-20 07:12AM  
Feb-27-20 05:54PM  
Feb-26-20 04:05PM  
Feb-21-20 10:20AM  
Feb-19-20 04:05PM  
Feb-12-20 04:05PM  
Feb-10-20 08:44AM  
Feb-03-20 11:27AM  
Jan-31-20 11:52AM  
Jan-29-20 09:50AM  
Jan-23-20 08:53PM  
Jan-22-20 08:25AM  
Jan-21-20 04:39PM  
04:02PM  
Jan-13-20 07:30AM  
Jan-08-20 07:30AM  
Dec-30-19 04:05PM  
10:04AM  
Dec-26-19 02:47PM  
Dec-20-19 04:17PM  
Dec-16-19 09:24PM  
Dec-13-19 04:52AM  
Dec-09-19 08:44AM  
08:00AM  
Dec-04-19 04:30PM  
Dec-03-19 04:34PM  
Nov-22-19 03:01AM  
Nov-19-19 12:26PM  
Nov-12-19 04:05PM  
Nov-11-19 09:28AM  
Oct-29-19 04:05PM  
Oct-14-19 06:43PM  
Oct-09-19 08:37AM  
Sep-26-19 07:13AM  
Sep-25-19 08:44AM  
Sep-24-19 08:00AM  
Sep-17-19 08:00AM  
Sep-08-19 07:45PM  
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test; and Amgen to develop a therapeutic to prevent or treat COVID-19. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBINS HARLAN SChief Scientific OfficerSep 24Option Exercise6.3211,10070,15211,779Sep 24 08:24 PM
ROBINS HARLAN SChief Scientific OfficerSep 24Sale47.1111,100522,879679Sep 24 08:24 PM
ROBINS HARLAN SChief Scientific OfficerSep 23Option Exercise6.3211,10070,15211,779Sep 24 08:24 PM
ROBINS HARLAN SChief Scientific OfficerSep 23Sale48.1611,100534,576679Sep 24 08:24 PM
ROBINS HARLAN SChief Scientific OfficerSep 22Option Exercise6.3211,10070,15211,779Sep 24 08:24 PM
ROBINS HARLAN SChief Scientific OfficerSep 22Sale47.5711,100527,975679Sep 24 08:24 PM
BENZENO SHARONChief Business Development OffSep 21Option Exercise6.274172,615417Sep 23 08:00 PM
BENZENO SHARONChief Business Development OffSep 21Sale45.5141718,9780Sep 23 08:00 PM
ROBINS CHAD MCEO and ChairmanSep 18Option Exercise0.3316,6805,5041,794,860Sep 18 09:00 PM
ROBINS CHAD MCEO and ChairmanSep 18Sale45.7216,680762,5631,778,180Sep 18 09:00 PM
ROBINS CHAD MCEO and ChairmanSep 17Option Exercise0.3316,6805,5041,794,860Sep 18 09:00 PM
ROBINS CHAD MCEO and ChairmanSep 17Sale45.1416,680752,9091,778,180Sep 18 09:00 PM
ROBINS CHAD MCEO and ChairmanSep 16Option Exercise0.3316,6805,5041,794,860Sep 18 09:00 PM
ROBINS CHAD MCEO and ChairmanSep 16Sale46.4416,680774,6051,738,680Sep 18 09:00 PM
HERSHBERG ROBERTDirectorSep 15Option Exercise0.452,0009002,000Sep 16 09:00 PM
LO FRANCISChief People OfficerSep 15Option Exercise7.802,00015,6002,000Sep 16 09:00 PM
SANG CHARLESSVP, External AffairsSep 15Option Exercise6.3225,000158,00025,000Sep 16 09:00 PM
HERSHBERG ROBERTDirectorSep 15Sale42.582,00085,1600Sep 16 09:00 PM
LO FRANCISChief People OfficerSep 15Sale42.582,00085,1600Sep 16 09:00 PM
SANG CHARLESSVP, External AffairsSep 15Sale44.0025,0001,100,0000Sep 16 09:00 PM
SANG CHARLESSVP, External AffairsSep 14Option Exercise6.5525,000163,75025,000Sep 16 09:00 PM
SANG CHARLESSVP, External AffairsSep 14Sale42.5025,0001,062,5000Sep 16 09:00 PM
Cohen Chad MChief Financial OfficerSep 11Option Exercise6.328,58854,2769,588Sep 11 09:00 PM
BALDO LANCEChief Medical OfficerSep 11Option Exercise7.804,14932,3624,149Sep 11 09:00 PM
BALDO LANCEChief Medical OfficerSep 11Sale40.004,149165,9600Sep 11 09:00 PM
Cohen Chad MChief Financial OfficerSep 11Sale40.008,588343,5201,000Sep 11 09:00 PM
Cohen Chad MChief Financial OfficerSep 10Option Exercise6.321,4128,9242,412Sep 11 09:00 PM
BALDO LANCEChief Medical OfficerSep 10Option Exercise7.801814018Sep 11 09:00 PM
BALDO LANCEChief Medical OfficerSep 10Sale40.00187200Sep 11 09:00 PM
Cohen Chad MChief Financial OfficerSep 10Sale40.001,41256,4801,000Sep 11 09:00 PM
Cohen Chad MChief Financial OfficerSep 08Option Exercise6.3220,000126,40021,000Sep 09 07:00 PM
BALDO LANCEChief Medical OfficerSep 08Option Exercise7.802,08316,2472,083Sep 09 07:00 PM
Cohen Chad MChief Financial OfficerSep 08Sale36.1720,000723,4001,000Sep 09 07:00 PM
BALDO LANCEChief Medical OfficerSep 08Sale36.172,08375,3420Sep 09 07:00 PM
BENZENO SHARONChief Business Development OffSep 01Option Exercise6.726,77145,4756,771Sep 02 08:00 PM
BENZENO SHARONChief Business Development OffSep 01Sale41.306,771279,6480Sep 02 08:00 PM
Taylor Stacy LSVP and General CounselAug 24Option Exercise7.032,88020,2504,180Aug 24 08:00 PM
Taylor Stacy LSVP and General CounselAug 24Sale42.582,880122,6351,300Aug 24 08:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 21Option Exercise6.3211,10070,15211,779Aug 24 08:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 21Sale43.1211,100478,658679Aug 24 08:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 20Option Exercise6.3211,10070,15211,779Aug 24 08:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 20Sale42.9311,100476,527679Aug 24 08:00 PM
BENZENO SHARONChief Business Development OffAug 19Option Exercise6.274162,608416Aug 19 08:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 19Option Exercise6.3211,10070,15211,779Aug 24 08:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 19Sale42.4811,100471,513679Aug 24 08:00 PM
BENZENO SHARONChief Business Development OffAug 19Sale41.5741617,2930Aug 19 08:00 PM
LO FRANCISChief People OfficerAug 17Option Exercise7.802,00015,6002,000Aug 19 08:00 PM
Cohen Chad MChief Financial OfficerAug 17Option Exercise6.3210,00063,20011,000Aug 19 08:00 PM
HERSHBERG ROBERTDirectorAug 17Option Exercise0.452,0009002,000Aug 19 08:00 PM
LO FRANCISChief People OfficerAug 17Sale39.362,00078,7250Aug 19 08:00 PM
HERSHBERG ROBERTDirectorAug 17Sale39.392,00078,7710Aug 19 08:00 PM
Cohen Chad MChief Financial OfficerAug 17Sale40.0010,000400,0001,000Aug 19 08:00 PM
ROBINS CHAD MCEO and ChairmanAug 12Option Exercise0.3316,6805,5041,794,860Aug 12 09:00 PM
ROBINS CHAD MCEO and ChairmanAug 12Sale37.427,675287,1821,787,185Aug 12 09:00 PM
ROBINS CHAD MCEO and ChairmanAug 11Option Exercise0.3316,6805,5041,794,860Aug 12 09:00 PM
ROBINS CHAD MCEO and ChairmanAug 11Sale37.2016,680620,5581,778,180Aug 12 09:00 PM
Cohen Chad MChief Financial OfficerAug 10Option Exercise6.3220,000126,40021,000Aug 12 08:00 PM
ROBINS CHAD MCEO and ChairmanAug 10Option Exercise0.3316,6805,5041,794,860Aug 12 09:00 PM
Cohen Chad MChief Financial OfficerAug 10Sale37.7820,000755,6001,000Aug 12 08:00 PM
ROBINS CHAD MCEO and ChairmanAug 10Sale37.6316,680627,6681,778,180Aug 12 09:00 PM
BALDO LANCEChief Medical OfficerAug 06Option Exercise7.806,25048,7506,250Aug 07 08:00 PM
BALDO LANCEChief Medical OfficerAug 06Sale40.006,250250,0000Aug 07 08:00 PM
BENZENO SHARONChief Business Development OffAug 04Option Exercise6.697,18748,1047,187Aug 05 09:00 PM
BENZENO SHARONChief Business Development OffAug 04Sale40.007,187287,4800Aug 05 09:00 PM
HILL NANCY LOUISEEVP, Operations & Program ManaAug 03Option Exercise0.841,6001,34411,600Aug 05 09:00 PM
HILL NANCY LOUISEEVP, Operations & Program ManaAug 03Sale37.371,60059,79210,000Aug 05 09:00 PM
ROBINS CHAD MCEO and ChairmanJul 31Option Exercise0.3316,6805,5041,794,860Jul 31 09:05 PM
ROBINS CHAD MCEO and ChairmanJul 31Sale37.2316,680621,0491,778,180Jul 31 09:05 PM
ROBINS CHAD MCEO and ChairmanJul 30Option Exercise0.3316,6805,5041,794,860Jul 31 09:05 PM
ROBINS CHAD MCEO and ChairmanJul 30Sale37.7616,680629,9111,778,180Jul 31 09:05 PM
ROBINS CHAD MCEO and ChairmanJul 29Option Exercise0.3320,6686,8201,798,848Jul 31 09:05 PM
ROBINS CHAD MCEO and ChairmanJul 29Sale38.1420,668788,2781,778,180Jul 31 09:05 PM
Taylor Stacy LSVP and General CounselJul 24Option Exercise7.032,88020,2504,180Jul 24 09:00 PM
Taylor Stacy LSVP and General CounselJul 24Sale36.032,880103,7661,300Jul 24 09:00 PM
BENZENO SHARONChief Business Development OffJul 20Option Exercise6.274172,615417Jul 21 08:47 AM
GOEL DAVID E.DirectorJul 20Sale40.002,000,00080,000,00013,115,090Jul 22 04:15 PM
BENZENO SHARONChief Business Development OffJul 20Sale40.0041716,6800Jul 21 08:47 AM
ROBINS HARLAN SChief Scientific OfficerJul 17Option Exercise6.3211,10070,15211,779Jul 17 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 17Sale39.6011,100439,611679Jul 17 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 16Option Exercise6.3222,200140,30422,879Jul 17 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 16Sale39.5722,200878,369679Jul 17 09:00 PM
LO FRANCISChief People OfficerJul 15Option Exercise7.802,00015,6002,000Jul 17 09:00 PM
HERSHBERG ROBERTDirectorJul 15Option Exercise0.452,0009002,000Jul 17 09:00 PM
HERSHBERG ROBERTDirectorJul 15Sale43.852,00087,6900Jul 17 09:00 PM
LO FRANCISChief People OfficerJul 15Sale43.862,00087,7100Jul 17 09:00 PM
RUBINSTEIN JULIEPresidentJul 09Option Exercise0.8415,27512,83115,275Jul 10 08:00 PM
HILL NANCY LOUISEEVP, Operations & Program ManaJul 09Option Exercise0.8417,40014,61627,400Jul 10 08:00 PM
RUBINSTEIN JULIEPresidentJul 09Sale49.0015,275748,4750Jul 10 08:00 PM
HILL NANCY LOUISEEVP, Operations & Program ManaJul 09Sale49.0017,400852,60010,000Jul 10 08:00 PM
Cohen Chad MChief Financial OfficerJul 08Option Exercise6.3230,000189,60031,000Jul 10 08:00 PM
Cohen Chad MChief Financial OfficerJul 08Sale46.8730,0001,406,0731,000Jul 10 08:00 PM
BALDO LANCEChief Medical OfficerJul 06Option Exercise7.806,25048,7506,250Jul 08 08:10 PM
DOBMEIER ERICDirectorJul 06Option Exercise6.3210,00063,20010,000Jul 08 08:28 PM
BALDO LANCEChief Medical OfficerJul 06Sale47.336,250295,7890Jul 08 08:10 PM
DOBMEIER ERICDirectorJul 06Sale47.3710,000473,6560Jul 08 08:28 PM
BENZENO SHARONChief Business Development OffJul 01Option Exercise6.726,77145,4756,771Jul 02 07:00 PM
HILL NANCY LOUISEEVP, Operations & Program ManaJul 01Option Exercise0.843,0002,52013,000Jul 02 07:00 PM
BENZENO SHARONChief Business Development OffJul 01Sale47.346,771320,5400Jul 02 07:00 PM
HILL NANCY LOUISEEVP, Operations & Program ManaJul 01Sale47.423,000142,26610,000Jul 02 07:00 PM
BENZENO SHARONChief Business Development OffJun 26Option Exercise6.324172,635417Jun 30 08:25 PM